Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume 65, Issue 12, Pages 1925-1966
Publisher
Springer Science and Business Media LLC
Online
2022-09-24
DOI
10.1007/s00125-022-05787-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2022 National Standards for Diabetes Self-Management Education and Support
- (2022) Jody Davis et al. DIABETES CARE
- Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
- (2022) Alison K. Wright et al. DIABETES CARE
- Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes
- (2022) Sabine Kahl et al. DIABETES OBESITY & METABOLISM
- Cardiovascular and Renal Outcomes with Canagliflozin in Patients with Peripheral Artery Disease: Data from the CANVAS program and CREDENCE trials
- (2022) Jennifer Y Barraclough et al. DIABETES OBESITY & METABOLISM
- Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes
- (2022) Dominik Dahl et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine
- (2022) JILL A. KANALEY et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings
- (2022) Esra Tasali et al. JAMA Internal Medicine
- Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease
- (2022) Mukul Bhattarai et al. JAMA Network Open
- Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
- (2022) Mansoor Husain et al. Cardiovascular Diabetology
- Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar
- (2022) Felicia Hill-Briggs et al. Current Diabetes Reports
- Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study
- (2022) et al. DIABETES CARE
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
- (2022) Thomas Karagiannis et al. DIABETOLOGIA
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
- (2022) Naveed Sattar et al. NATURE MEDICINE
- Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
- (2022) Brian S. Wojeck et al. Sleep and Breathing
- Effects of sleep manipulation on markers of insulin sensitivity: A systematic review and meta-analysis of randomized controlled trials
- (2022) Nina Sondrup et al. SLEEP MEDICINE REVIEWS
- Dose-Dependent Effect of Supervised Aerobic Exercise on HbA1c in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
- (2022) Ahmad Jayedi et al. SPORTS MEDICINE
- Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
- (2022) W. David Strain et al. STROKE
- Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
- (2022) Liyun He et al. JAMA Internal Medicine
- Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
- (2022) Amalia Gastaldelli et al. Lancet Diabetes & Endocrinology
- Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal–Bolus Insulin Regimen: A Prospective Randomized Study
- (2022) Sol Batule et al. Journal of Clinical Medicine
- Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies
- (2022) Thomas Crabtree et al. Expert Review of Endocrinology & Metabolism
- Manufacturing with pluripotent stem cells ( PSConf 2021): Key issues for future research and development
- (2022) Glyn N. Stacey et al. CELL PROLIFERATION
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa
- (2022) Michelle Lowe et al. Frontiers in Microbiology
- Polydatin activates the Nrf2/HO-1 signaling pathway to protect cisplatin-induced hearing loss in guinea pigs
- (2022) Dafei Li et al. Frontiers in Pharmacology
- Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
- (2021) Juan P. Frias et al. DIABETES CARE
- A global perspective on the issue of access to insulin
- (2021) David Beran et al. DIABETOLOGIA
- The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes
- (2021) Niels B Dalsgaard et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
- (2021) Geltrude Mingrone et al. LANCET
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58
- (2021) Avivit Cahn et al. DIABETES CARE
- SGLT ‐2 inhibitors for prevention of cardiorenal outcomes in type 2 diabetes: an updated meta‐analysis.
- (2021) Dario Giugliano et al. DIABETES OBESITY & METABOLISM
- GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis
- (2021) Thomas Karagiannis et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User Utility Score for Diabetes Management Using Tailored Mobile Coaching: Secondary Analysis of a Randomized Controlled Trial
- (2021) Min-Kyung Lee et al. JMIR mHealth and uHealth
- Frequency of Interruptions to Sitting Time: Benefits for Postprandial Metabolism in Type 2 Diabetes
- (2021) Ashleigh R. Homer et al. DIABETES CARE
- Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis
- (2021) Maximilian Gabler et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Does Lifestyle Intervention Improve Health of Adults with Overweight/Obesity and Type 2 Diabetes: Findings from the Look AHEAD Randomized Trial
- (2021) Rena R. Wing et al. Obesity
- Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes
- (2021) Ali Aminian et al. ANNALS OF SURGERY
- The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
- (2021) Tu N. Nguyen et al. DIABETES CARE
- Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
- (2021) Matthew C. Riddle et al. DIABETES CARE
- Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
- (2021) Marcus Lind et al. DIABETES CARE
- Comparative efficacy of glucose‐lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta‐analysis
- (2021) Apostolos Tsapas et al. DIABETES OBESITY & METABOLISM
- GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials
- (2021) Apostolos Tsapas et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: A systematic review and meta-analysis of randomized controlled trials
- (2021) Xue Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
- (2021) Giuseppe Della Pepa et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials
- (2021) Donna Shu-Han Lin et al. DIABETOLOGIA
- Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature
- (2021) Samantha B. J. Schipper et al. DIABETOLOGIA
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
- (2021) Thomas Martens et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- (2021) Bernhard Ludvik et al. LANCET
- Advancing the Learning Health System
- (2021) J. Michael McGinnis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Complications in Youth-Onset Type 2 Diabetes
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Long‐term health benefits of intensive lifestyle intervention in the Look AHEAD study
- (2021) W. Timothy Garvey Obesity
- Network Meta-Analysis of Metabolic Surgery Procedures for the Treatment of Obesity and Diabetes
- (2021) Andrew C. Currie et al. OBESITY SURGERY
- Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
- (2021) Wen-Hsuan Tsai et al. Scientific Reports
- Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
- (2021) Juan P Frías et al. Lancet Diabetes & Endocrinology
- Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Mikhail N Kosiborod et al. Lancet Diabetes & Endocrinology
- Rationality, Efficacy, Tolerability of Empagliflozin plus Linagliptin Combination for the Management of Type 2 Diabetes Mellitus: A Systematic review of randomized controlled trials and observational studies.
- (2021) Santenna Chenchul et al. CURRENT DIABETES REVIEWS
- Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial
- (2021) Hiddo J.L. Heerspink et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease
- (2021) Elisabetta Patorno et al. ANNALS OF INTERNAL MEDICINE
- Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial
- (2021) Carolyn S.P. Lam et al. CIRCULATION
- Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
- (2021) Ahmed M. Shaman et al. CIRCULATION
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Introduction: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews
- (2021) Nanna Lindekilde et al. DIABETOLOGIA
- Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial
- (2021) Marie Pigeyre et al. DIABETOLOGIA
- Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
- (2021) Stefano Del Prato et al. LANCET
- Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
- (2021) Ildiko Lingvay et al. LANCET
- Insulin discovery: A pivotal point in medical history
- (2021) Pierpaolo Falcetta et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial
- (2021) Christian T. Ruff et al. NATURE MEDICINE
- Advancing the global public health agenda for NAFLD: a consensus statement
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Comparative Effectiveness of Bariatric Surgeries in Patients with Type 2 Diabetes Mellitus and BMI ≥ 25 kg/m2: a Systematic Review and Network Meta-Analysis
- (2021) Maria Neves Carmona et al. OBESITY SURGERY
- Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
- (2021) Muhammad Yazid Jalaludin et al. PEDIATRIC DIABETES
- Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice
- (2021) Sean Wharton et al. POSTGRADUATE MEDICINE
- Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials
- (2021) Sophie Sun et al. THERAPIE
- A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
- (2021) Samit Ghosal et al. Scientific Reports
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Diabetes mellitus correlates with increased biological age as indicated by clinical biomarkers
- (2021) Nadine Bahour et al. GeroScience
- Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial
- (2021) Matthew M.Y. Lee et al. Diabetes & Metabolic Syndrome-Clinical Research & Reviews
- Changes in dietary intake improve glycemic control following a structured nutrition therapy during Ramadan in individuals with type 2 diabetes
- (2021) Barakatun-Nisak Mohd Yusof et al. Clinical Nutrition ESPEN
- Glucagon-like Peptide-1 Receptor Agonists and Cardioprotective Benefit in Patients with Type 2 Diabetes Without Baseline Metformin: A Systematic Review and Update Meta-analysis
- (2021) Augusto Lavalle-Cobo et al. High Blood Pressure & Cardiovascular Prevention
- The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and Meta-Regression
- (2021) Stine Hangaard et al. Journal of diabetes science and technology
- Effect of high-intensity interval training protocols on VO2max and HbA1c level in people with type 2 diabetes: A systematic review and meta-analysis
- (2021) Mariana Brondani de Mello et al. Annals of Physical and Rehabilitation Medicine
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
- (2020) Niki Katsiki et al. DIABETES OBESITY & METABOLISM
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- Sex Disparities in Cardiovascular Outcome Trials of Populations With Diabetes: A Systematic Review and Meta-analysis
- (2020) Kristin K. Clemens et al. DIABETES CARE
- Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
- (2020) Vlado Perkovic et al. DIABETES CARE
- Metabolic surgery for the treatment of type 2 diabetes: A network meta‐analysis of randomized controlled trials
- (2020) Barbara Cresci et al. DIABETES OBESITY & METABOLISM
- Association of Daily Step Count and Step Intensity With Mortality Among US Adults
- (2020) Pedro F. Saint-Maurice et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients
- (2020) Barakatun-Nisak Mohd Yusof et al. Nutrients
- Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
- (2020) Apostolos Tsapas et al. ANNALS OF INTERNAL MEDICINE
- Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
- (2020) Stefan Schandelmaier et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Sleep Regularity and Cardiometabolic Heath: Is Variability in Sleep Patterns a Risk Factor for Excess Adiposity and Glycemic Dysregulation?
- (2020) Faris M. Zuraikat et al. Current Diabetes Reports
- Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
- (2020) Matthew J. Crowley et al. DIABETES CARE
- Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association
- (2020) Margaret A. Powers et al. DIABETES CARE
- Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
- (2020) Chrysanthi Mantsiou et al. DIABETES OBESITY & METABOLISM
- Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials
- (2020) Jack A. Sargeant et al. DIABETOLOGIA
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials
- (2020) B-B. Qian et al. OSTEOPOROSIS INTERNATIONAL
- Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities
- (2020) Velandai Srikanth et al. Lancet Diabetes & Endocrinology
- Physical behaviors and chronotype in people with type 2 diabetes
- (2020) Joseph Henson et al. BMJ Open Diabetes Research & Care
- Wrist-worn accelerometers: recommending ~1.0 mg as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults
- (2020) Alex Rowlands et al. BRITISH JOURNAL OF SPORTS MEDICINE
- Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study
- (2020) Juliana C. N. Chan et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitors with and without metformin: a meta‐analysis of cardiovascular, kidney and mortality outcomes
- (2020) Brendon L Neuen et al. DIABETES OBESITY & METABOLISM
- Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose
- (2020) Selvam Kasthuri et al. Diabetes Technology & Therapeutics
- Effects of sodium‐glucose co‐transporter 2 inhibitors on liver parameters and steatosis: A meta‐analysis of randomized clinical trials
- (2020) Francisca dos Santos Coelho et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Device‐measured physical activity and its association with physical function in adults with type 2 diabetes mellitus
- (2020) M. Mickute et al. DIABETIC MEDICINE
- Web-Based Interventions for Dietary Behavior in Adults With Type 2 Diabetes: Systematic Review of Randomized Controlled Trials
- (2020) Jedha Dening et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes
- (2020) David Matthews et al. Diabetes Therapy
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- World Health Organization 2020 guidelines on physical activity and sedentary behaviour
- (2020) Fiona C Bull et al. BRITISH JOURNAL OF SPORTS MEDICINE
- Risk of Cardiovascular Outcomes in Type 2 Diabetes Patients Following Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-IRA Therapy
- (2020) Chintan V. Dave et al. CIRCULATION
- Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
- (2020) Muhammad Abdul-Ghani et al. DIABETES CARE
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
- (2020) M. Angelyn Bethel et al. DIABETES CARE
- Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steatohepatitis: A hierarchical network meta‐analysis
- (2020) Simona Panunzi et al. DIABETES OBESITY & METABOLISM
- Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management
- (2020) Aisling Smyth et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Use of MyDesmond digital education programme to support self‐management in people with type 2 diabetes during the COVID‐19 pandemic
- (2020) Lauren M. Quinn et al. DIABETIC MEDICINE
- Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery
- (2020) Maria Francesca Russo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Digital Coaching Strategies to Facilitate Behavioral Change in Type 2 Diabetes: A Systematic Review
- (2020) Bradley D Gershkowitz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
- (2020) Juliana C N Chan et al. LANCET
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development
- (2020) Pinelopi Konstantinou et al. Translational Behavioral Medicine
- SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews
- (2020) Shih-Chieh Shao et al. BMJ Open Diabetes Research & Care
- Effect of Telemetric Interventions on Glycated Hemoglobin A1c and Management of Type 2 Diabetes Mellitus: Systematic Meta-Review
- (2020) Claudia Eberle et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Next Generation of Diabetes Translation: A Path to Health Equity
- (2019) Debra Haire-Joshu et al. Annual Review of Public Health
- Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI
- (2019) Matilde Rubio-Almanza et al. OBESITY SURGERY
- Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2019) Tamara Milder et al. Journal of Clinical Medicine
- Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
- (2019) Michael E J Lean et al. Lancet Diabetes & Endocrinology
- Pioglitazone Therapy in Patients With Stroke and Prediabetes
- (2019) J. David Spence et al. JAMA Neurology
- Dietary Patterns and Management Of Type 2 Diabetes: A Systematic Review Of Randomised Clinical Trials
- (2019) Dimitra Papamichou et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial
- (2019) S. Carter et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Ad libitum Weekend Recovery Sleep Fails to Prevent Metabolic Dysregulation during a Repeating Pattern of Insufficient Sleep and Weekend Recovery Sleep
- (2019) Christopher M. Depner et al. CURRENT BIOLOGY
- The Mediterranean Diet and Cardiovascular Health
- (2019) Miguel A. Martínez-González et al. CIRCULATION RESEARCH
- Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
- (2019) Alison B. Evert et al. DIABETES CARE
- Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
- (2019) Richard M. Bergenstal et al. Diabetes Technology & Therapeutics
- Resurgence in Diabetes-Related Complications
- (2019) Edward W. Gregg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Team-Based Care to Improve Diabetes Management: A Community Guide Meta-analysis
- (2019) Timothy W. Levengood et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study
- (2019) Yogini V. Chudasama et al. BMC Medicine
- Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
- (2019) DIABETES CARE
- Do GLP‐1RA and SGLT‐2i reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis
- (2019) Basem M Mishriky et al. DIABETES OBESITY & METABOLISM
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial
- (2019) Lawrence Blonde et al. DIABETES CARE
- Impact of technology on glycaemic control in type 2 diabetes: A meta‐analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion
- (2019) Ilaria Dicembrini et al. DIABETES OBESITY & METABOLISM
- Effects of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes in women versus men
- (2019) Karin Rådholm et al. DIABETES OBESITY & METABOLISM
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
- (2019) David R Matthews et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Creating a Learning Health System through Rapid-Cycle, Randomized Testing
- (2019) Leora I. Horwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis
- (2019) E. G. Dorsey-Treviño et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
- (2019) Vanita R Aroda et al. Lancet Diabetes & Endocrinology
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial
- (2019) Lindsay E. Clegg et al. Cardiovascular Diabetology
- GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
- (2019) Nancy Santesso et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies
- (2019) Mark Evans et al. Diabetes Therapy
- 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETOLOGIA
- Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016
- (2019) Linda J. Andes et al. JAMA Pediatrics
- Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes
- (2019) Antonio Nicolucci et al. Diabetes Therapy
- Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: a systematic review including GRADE assessments
- (2018) Esther J van Zuuren et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes
- (2018) Anastasia-Vasiliki Madenidou et al. ANNALS OF INTERNAL MEDICINE
- Sex Differences in the Burden and Complications of Diabetes
- (2018) Sanne A. E. Peters et al. Current Diabetes Reports
- A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks
- (2018) Matthew C. Riddle et al. DIABETES CARE
- Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
- (2018) DIABETES CARE
- Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4
- (2018) Jean-Daniel Lalau et al. DIABETES CARE
- Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials
- (2018) Francesco Zaccardi et al. DIABETES OBESITY & METABOLISM
- Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
- (2018) Maria Ida Maiorino et al. DIABETES OBESITY & METABOLISM
- Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
- (2018) Tina Vilsbøll et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis
- (2018) Dandan Li et al. DIABETES OBESITY & METABOLISM
- Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis
- (2018) Emma Sainsbury et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial
- (2018) B. T. Corley et al. DIABETIC MEDICINE
- A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus
- (2018) Lukas Schwingshackl et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The effect of nurse prescribers on glycaemic control in type 2 diabetes: A systematic review and meta -analysis
- (2018) Maryam Tabesh et al. INTERNATIONAL JOURNAL OF NURSING STUDIES
- Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial
- (2018) Mattijs Out et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
- (2018) Guillermo E. Umpierrez et al. Journal of the American Medical Directors Association
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
- (2018) Michael EJ Lean et al. LANCET
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
- (2018) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
- (2018) Adham Mottalib et al. Nutrition Journal
- The Effects of Postprandial Exercise on Glucose Control in Individuals with Type 2 Diabetes: A Systematic Review
- (2018) Andrew Borror et al. SPORTS MEDICINE
- Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis
- (2018) Se Hee Min et al. Scientific Reports
- Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice
- (2018) Lutz Heinemann et al. Journal of Diabetes Research
- Do sulphonylureas still have a place in clinical practice?
- (2018) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- Diabetes structured self-management education programmes: a narrative review and current innovations
- (2018) Sudesna Chatterjee et al. Lancet Diabetes & Endocrinology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
- (2018) Bei Pan et al. International Journal of Behavioral Nutrition and Physical Activity
- Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis
- (2018) Xiaoling Cai et al. Diabetes Therapy
- GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
- (2018) Marco Castellana et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials
- (2018) Zhamak Khorgami et al. OBESITY SURGERY
- Supported self-management for people with type 2 diabetes: a meta-review of quantitative systematic reviews
- (2018) Mireille Captieux et al. BMJ Open
- Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study
- (2017) Denise K Houston et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- (2017) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis
- (2017) Shaun Wen Huey Lee et al. SLEEP MEDICINE REVIEWS
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Clinical inertia—Time to reappraise the terminology?
- (2017) Kamlesh Khunti et al. Primary Care Diabetes
- Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial
- (2017) Jo-Anne Manski-Nankervis et al. Primary Care Diabetes
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings
- (2017) Laura A. Young et al. JAMA Internal Medicine
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
- (2017) Olga Vaccaro et al. Lancet Diabetes & Endocrinology
- What Is Shared Decision Making? (and What It Is Not)
- (2016) Marleen Kunneman et al. ACADEMIC EMERGENCY MEDICINE
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program
- (2016) Hui Peng et al. Current Diabetes Reports
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
- (2016) Francesco Rubino et al. DIABETES CARE
- Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial
- (2016) Vanita R. Aroda et al. DIABETES CARE
- Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association
- (2016) Deborah Young-Hyman et al. DIABETES CARE
- Benefits for Type 2 Diabetes of Interrupting Prolonged Sitting With Brief Bouts of Light Walking or Simple Resistance Activities
- (2016) Paddy C. Dempsey et al. DIABETES CARE
- Triple therapy combinations for the treatment of type 2 diabetes – A network meta-analysis
- (2016) Crystal Man Ying Lee et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes
- (2016) Ildiko Lingvay et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Theory-based self-management educational interventions on patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2016) Fang-Fang Zhao et al. JOURNAL OF ADVANCED NURSING
- Pioglitazone and Risk for Bone Fracture: Safety Data from a Randomized Clinical Trial
- (2016) Catherine M. Viscoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
- (2016) Vanita R. Aroda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes
- (2016) Patrick M. O'Neil et al. Obesity
- Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control
- (2016) Carole A. Chrvala et al. PATIENT EDUCATION AND COUNSELING
- Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
- (2016) Carola A Huber et al. Patient Preference and Adherence
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
- (2016) William Polonsky et al. Patient Preference and Adherence
- A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
- (2016) Robert G. Moses et al. Journal of Diabetes
- Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes
- (2016) Jens Sandahl Christiansen et al. Journal of Diabetes
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Shared decision making in endocrinology: present and future directions
- (2016) Rene Rodriguez-Gutierrez et al. Lancet Diabetes & Endocrinology
- Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study
- (2016) Jack R W Brownrigg et al. Lancet Diabetes & Endocrinology
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- Behavioral Programs for Type 2 Diabetes Mellitus
- (2015) Jennifer Pillay et al. ANNALS OF INTERNAL MEDICINE
- The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes
- (2015) Tamara S. Hannon et al. Annals of the New York Academy of Sciences
- Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
- (2015) Judith G. Regensteiner et al. CIRCULATION
- Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes
- (2015) Kristy Iglay et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial
- (2015) A Ram Hong et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis
- (2015) E. S. Mearns et al. DIABETIC MEDICINE
- Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2015) Silvio E. Inzucchi et al. DIABETOLOGIA
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple therapy in type 2 diabetes; a systematic review and network meta-analysis
- (2015) Martin J. Downes et al. PeerJ
- Longitudinal Effects of Medication Nonadherence on Glycemic Control
- (2014) Leonard E. Egede et al. ANNALS OF PHARMACOTHERAPY
- Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)
- (2014) John B. Buse et al. DIABETES CARE
- Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events
- (2014) Sanne A. E. Peters et al. DIABETOLOGIA
- How to Use a Subgroup Analysis
- (2014) Xin Sun et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Magnitude of Cognitive Dysfunction in Adults with Type 2 Diabetes: A Meta-analysis of Six Cognitive Domains and the Most Frequently Reported Neuropsychological Tests Within Domains
- (2014) Priya Palta et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes
- (2014) Sanne A E Peters et al. LANCET
- Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and -Cell Function in TODAY
- (2013) DIABETES CARE
- A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
- (2013) R. G. Moses et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
- (2013) V. Lukashevich et al. DIABETES OBESITY & METABOLISM
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
- (2013) Jeff Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis
- (2013) Thomas Yates et al. LANCET
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- The Diabetes Mellitus Medication Choice Decision Aid
- (2009) Rebecca J. Mullan et al. ARCHIVES OF INTERNAL MEDICINE
- Cardiovascular risk assessment scores for people with diabetes: a systematic review
- (2009) P. Chamnan et al. DIABETOLOGIA
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes
- (2008) Maggie Breslin et al. PATIENT EDUCATION AND COUNSELING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation